Markers of cardio-vascular remodeling in hypertension;Marqueurs du remodelage cardiovasculaire structural et fonctionnel dans l'hypertension

Archives des Maladies du Coeur et des Vaisseaux

Volumn 96, Issue 7-8, 2003, Pages 729-733

  Legedz, L ^a   Rial, M O ^a   Lantelme, P ^a   Champomier, P ^a   Cerutti, C ^b   Vincent, M ^c   Bricca, G ^b   Milon, H ^a  

^a CROIX ROUSSE HOSPITAL   (France)

^b INSERM   (France)

^c UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT; CALCIUM ANTAGONIST; CATECHOLAMINE; NORADRENALIN; RENIN;

ADRENERGIC SYSTEM; ADULT; AGED; ARTERY DIAMETER; ARTICLE; ECHOCARDIOGRAPHY; FEMALE; HEART HYPERTROPHY; HEART LEFT VENTRICLE; HEART VENTRICLE REMODELING; HEMODYNAMICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERTENSION; IMMUNORADIOMETRIC ASSAY; MAJOR CLINICAL STUDY; MALE; PLASMA RENIN ACTIVITY; PULSE WAVE; RADIOIMMUNOASSAY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RIGIDITY; SYSTOLIC BLOOD PRESSURE;

EID: 0042091982     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Roman MJ, Saba PS, Pini R et al. Parallel cardiac and vascular adaptation in hypertension. Circulation 1992; 86: 1909-18.
2. Tedesco MA, Di Salvo G, Ratti G, Natale F, Iarussi D, Iacono A. Left atrial size in 164 hypertensive patients: an echocardiographic and ambulatory blood pressure study. Clin Cardiol 2001; 24: 603-7.
3. Guarini P, Tedeschi C, Giordano G, Messina V, Cicatello AM, Strollo L. Effects of hypertension on intimal-medial thickness, left ventricular mass and aortic distensibility. Int Angiol 1994; 13: 317-22.
4. Zoccali C, Mallamaci F, Tripepi G et al. Norepinephrine and concentric hypertrophy in patients with end-stage renal disease. Hypertension 2002; 40: 41-6.
5. Olsen MH, Wachtell K, Hermann KL et al. Is cardiovascular remodeling in patients with essential hypertension related to mare than hiqh blood pressure? A LIFE substudy. Losartan Intervention For Endpoint-Reduction in Hypertension. Am Heart J 2002; 144: 530-7.
6. Goldkorn R, Yurenev A, Blumenfeld J, Fishman D, Devereux RB. Echocardiographic comparison of left ventricular structure and function in hypertensive patients with primary aldosteronism and essential hypertension. Am J Hypertens 2002; 15: 340-5.
7. Rossi GP, Sacchetto A, Visentin P et al. Changes in left ventricular anatomy and function in hypertension and primary aldosteronism. Hypertension 1996; 27: 1039-45.
8. Gerdts E, Oikarinen L, Palmieri V et al. Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy. The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study. Hypertension 2002; 39: 739-43.
9. Mornex R, Peyrin L, Pagliari R, Cottet-Eymard JM. Measurement of plasma metaoxyamines for the diagnosis of pheochromocytoma. Hormon Res 1991; 36: 220-6.
10. Schirmer H, Lunde P, Rasmussen K. Mitral flow derived Doppler indices of left ventricular diastolic function in a general population; the Tromso study. Eur Heart J 2000; 21: 1298-300.